Rupa Mazumder | Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Rupa Mazumder
Noida Institute of Engineering And Technology

Rupa Mazumder
Affiliation Noida Institute of Engineering And Technology
Country India
Scopus ID 7005832705
Documents 211
Citations 1,412
h-index 18
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0002-1888-548X

Rupa Mazumder is a researcher affiliated with the Noida Institute of Engineering And Technology, India, whose documented scholarly profile is associated with toxicology and pharmaceutical science. The supplied Scopus record reports 211 documents, 1,412 citations, and an h-index of 18, providing a bibliometric basis for considering the researcher within an academic recognition framework. [1]

Abstract

Rupa Mazumder is an India-based researcher affiliated with the Noida Institute of Engineering And Technology and associated with the subject area of Toxicology and Pharmaceutical Science. The supplied bibliometric profile records 211 scholarly documents, 1,412 citations, and an h-index of 18. These indicators provide measurable evidence of sustained research activity and scholarly visibility. Her profile is considered in relation to the Best Researcher Award under the International Invention Awards framework. Assessment of researcher recognition may consider publication productivity, citation influence, research continuity, subject expertise, and the broader relevance of scientific contributions. Bibliometric information should be interpreted alongside verified qualitative evidence and individual research outputs for balanced academic evaluation.

Keywords

Rupa Mazumder; Best Researcher Award; Toxicology; Pharmaceutical Science; Drug Research; Pharmacology; Research Impact; Scholarly Publications; Citation Analysis; h-index; Scientific Research; International Invention Awards.

Introduction

Researcher recognition in pharmaceutical and toxicological sciences commonly involves consideration of scholarly productivity, research quality, citation performance, and sustained engagement with scientific questions. Bibliometric indicators can provide a structured quantitative perspective, although they do not independently establish the originality or practical significance of individual studies. The available profile for Rupa Mazumder presents a substantial publication and citation record that can be examined as part of a broader academic assessment. [1] Standardized researcher identifiers such as Scopus Author ID and ORCID can also assist in distinguishing scholarly outputs and improving the reliability of attribution. [2]

Research Profile

The supplied profile identifies Rupa Mazumder with the Noida Institute of Engineering And Technology in India and places the research activity within Toxicology and Pharmaceutical Science. The reported Scopus Author ID is 7005832705, while the associated ORCID is 0000-0002-1888-548X. These persistent identifiers provide complementary mechanisms for connecting scholarly records with an individual researcher and can support verification across academic databases. [1] [2]

Research Contributions

Within toxicology and pharmaceutical science, research contributions may encompass the investigation of drug effects, safety, pharmacological mechanisms, toxicological responses, therapeutic development, and related biomedical questions. The available information does not provide a complete thematic inventory of Rupa Mazumder’s individual studies, so specific scientific claims should be based on verified publication records rather than inferred solely from bibliometric indicators. The documented publication volume nevertheless indicates sustained participation in scholarly research. [1]

Publications

The supplied Scopus information records 211 documents associated with the researcher profile. Publication counts are useful for describing research productivity but should be evaluated with attention to document type, authorship, journal quality, research field, chronology, and subject relevance. A complete publication assessment would require examination of the underlying indexed records and individual bibliographic metadata. The reported document count is therefore presented as a profile-level bibliometric indicator rather than as an independent measure of research quality. [1]

Research Impact

The supplied profile reports 1,412 citations and an h-index of 18. Citation indicators can help describe the visibility and scholarly uptake of published research, while the h-index combines productivity and citation dimensions into a single metric. Such measures vary across disciplines, career stages, database coverage, and publication practices and should therefore be interpreted within appropriate academic context. [1] Citation-based assessment is strongest when complemented by qualitative evidence concerning originality, methodological contribution, collaboration, and influence on subsequent research.

Award Suitability

The available bibliometric information provides a relevant quantitative foundation for consideration for the Best Researcher Award. The combination of 211 reported documents, 1,412 citations, and an h-index of 18 indicates an established scholarly record within the supplied profile. [1] Final award suitability should, however, be determined through verification of the researcher identity, publication record, research quality, originality, professional contributions, and alignment with the applicable award criteria. The profile therefore supports consideration without implying that bibliometric measures alone determine award outcome.

Conclusion

Rupa Mazumder’s supplied academic profile documents substantial scholarly activity in the field of Toxicology and Pharmaceutical Science, with 211 documents, 1,412 citations, and an h-index of 18. These indicators establish a useful quantitative basis for academic recognition while requiring contextual interpretation. [1] Verification through persistent researcher identifiers, indexed publications, and qualitative evidence can strengthen the assessment. On the information provided, the profile presents a credible basis for consideration under the Best Researcher Award category of the International Invention Awards.

References

  1. Elsevier. (n.d.). Scopus author details: Rupa Mazumder, Author ID 7005832705. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7005832705
  2. ORCID. (n.d.). ORCID record: Rupa Mazumder, ORCID 0000-0002-1888-548X. ORCID.
    https://orcid.org/0000-0002-1888-548X
  3. Journal article. (2026).Preparations, Applications, Patents, and Marketed Formulations of Nanoemulsions – A Comprehensive Review.
    http://dx.doi.org/10.2174/0122117385325186240912110731
  4. Journal article. (2025). A Comprehensive Investigation on the Role of Bioactives on DYRK1A to Avert Alzheimer’s Disease.
    https://doi.org/10.18311/jnr/2025/49903
  5. International Invention Awards. (2026. ). Official award website.
    https://inventionawards.org/

Ghazaleh Pouya | Pharmacology | Young Researcher Award

Published on by Invention Awards

Ms. Ghazaleh Pouya | Pharmacology Science | Young Researcher Award

Ms. Ghazaleh Pouya | Sechenov University | Russia

Ms. Ghazaleh Pouya is an aspiring pharmaceutical scientist and multidisciplinary researcher, currently pursuing a Master’s degree in Biology at Sechenov University with a focus on Innovative Medicines. With a Doctor of Pharmacy (Pharm.D.) degree from the same university, she integrates her clinical pharmaceutical knowledge with advanced research in transdermal drug delivery and AI-powered biomedical solutions. As a lab assistant and assistant researcher, she actively contributes to academic publications, interdisciplinary projects, and data analytics in pharma-biotech. Her curiosity and dedication to translational medicine, wound healing systems, and personalized therapeutics reflect in her dynamic academic and research involvement, positioning her as a promising young innovator at the intersection of pharmacy, biology, and artificial intelligence.

Profile

ORCID

Education

Ms. Ghazaleh earned her Pharm.D. from Sechenov University, completing a thesis on in-vitro modeling of aero-dispersed film-forming systems. Currently, she is enrolled in a Master’s program in Biology, focusing on Innovative Medicines, at the same institution. In parallel, she undertakes applied IT training at School-21, a program dedicated to programming, app development, and clinical data analysis in medicine. Her multidisciplinary training bridges biological sciences, medical informatics, and pharmaceutical technologies. Ms. Ghazaleh’s strong academic background provides her with a unique perspective in drug delivery development and biomedical computation, preparing her for impactful contributions to pharmaceutical innovation and AI-assisted healthcare systems.

Experience

Ms. Ghazaleh Pouya is a laboratory assistant and student researcher at Sechenov University, actively involved in both experimental design and data analysis across pharmaceutical and biological domains, where she develops tools for clinical and pharmaceutical data evaluation. She collaborates with the Department of Pharmaceutical Technology, Department of Biology (Innovative Drugs), and the PHARMA-PREMIUM Scientific Research Center, contributing to a range of wound treatment, drug delivery, and AI-modeling projects. This diverse experience strengthens her competence in translational science, combining wet lab experimentation with computational modeling, ensuring real-world applicability of research findings.

Research Interests

Ms. Ghazaleh’s research focuses on transdermal drug delivery systems, pharmaceutical nanocarriers, and AI-integrated biomedical analytics. She is also exploring in vitro skin models, pharmacogenomics, and quality-by-design (QbD) strategies in formulation development. Her innovative mindset drives her to investigate how machine learning can optimize personalized drug delivery mechanisms, especially for wound treatment and skin permeability. She works on enhancing the bioavailability and targeted release of active substances using nano-based platforms, contributing to the next generation of smart drug delivery systems. Ghazaleh’s vision blends biological sciences, digital health, and pharmaceutical technology for patient-centered therapeutic innovations.

Award

Ms. Ghazaleh Pouya is a strong candidate for the “Young Researcher Award” under the International Invention Awards 2025. Her multidisciplinary background, three completed co-authored publications, ongoing research in pharmaceutical aerosols, and AI-driven drug delivery platforms reflect her impactful contributions at an early stage of her career. Her experience across pharmaceutical formulation, lab analytics, and computational modeling positions her among the emerging leaders in pharm-biotech research. Her self-driven participation in interdepartmental and interdisciplinary collaborations exemplifies the qualities of a future research innovator. This award would not only recognize her current achievements but also catalyze her continued excellence in translational research.

Publications

Transdermal Drug Delivery Systems: Methods for Enhancing Skin Permeability and Their Evaluation

Development of water vapor permeability determination methodology for spray film-forming systems

characterization and screening parameters of spray film-forming systems: a comprehensive study on dosage forms and quality indicators

Conclusion

Ms. Ghazaleh Pouya embodies the ideal profile of a rising biomedical innovator, integrating academic rigor, hands-on laboratory experience, and computational skills into a cohesive research journey. Her contributions to pharmaceutical sciences, particularly in film-forming drug systems and skin permeability, along with her novel integration of AI in drug delivery, showcase her potential to advance therapeutic design. With publications in reputable journals, active institutional collaborations, and an interdisciplinary mindset, she has already laid a strong foundation for a successful career in science and innovation. Recognition through the Young Researcher Award will further encourage her to expand her scientific impact and pursue future breakthroughs in personalized medicine and nanopharmaceuticals.